These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

103 related items for PubMed ID: 22643193

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Attributable hospital cost and antifungal treatment of invasive fungal diseases in high-risk hematology patients: an economic modeling approach.
    Ananda-Rajah MR, Cheng A, Morrissey CO, Spelman T, Dooley M, Neville AM, Slavin M.
    Antimicrob Agents Chemother; 2011 May; 55(5):1953-60. PubMed ID: 21357302
    [Abstract] [Full Text] [Related]

  • 3. Costs attributable to healthcare-acquired infection in hospitalized adults and a comparison of economic methods.
    Roberts RR, Scott RD, Hota B, Kampe LM, Abbasi F, Schabowski S, Ahmad I, Ciavarella GG, Cordell R, Solomon SL, Hagtvedt R, Weinstein RA.
    Med Care; 2010 Nov; 48(11):1026-35. PubMed ID: 20940650
    [Abstract] [Full Text] [Related]

  • 4. Adverse drug events in hospitalized patients. Excess length of stay, extra costs, and attributable mortality.
    Classen DC, Pestotnik SL, Evans RS, Lloyd JF, Burke JP.
    JAMA; 2010 Nov; 277(4):301-6. PubMed ID: 9002492
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Hospital-acquired, laboratory-confirmed bloodstream infection: increased hospital stay and direct costs.
    Orsi GB, Di Stefano L, Noah N.
    Infect Control Hosp Epidemiol; 2002 Apr; 23(4):190-7. PubMed ID: 12002233
    [Abstract] [Full Text] [Related]

  • 11. Hospital costs for treatment of acute heart failure: economic analysis of the REVIVE II study.
    de Lissovoy G, Fraeman K, Teerlink JR, Mullahy J, Salon J, Sterz R, Durtschi A, Padley RJ.
    Eur J Health Econ; 2010 Apr; 11(2):185-93. PubMed ID: 19582491
    [Abstract] [Full Text] [Related]

  • 12. The epidemiology and attributable outcomes of candidemia in adults and children hospitalized in the United States: a propensity analysis.
    Zaoutis TE, Argon J, Chu J, Berlin JA, Walsh TJ, Feudtner C.
    Clin Infect Dis; 2005 Nov 01; 41(9):1232-9. PubMed ID: 16206095
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Estimating the economic impact of a half-day reduction in length of hospital stay among patients with community-acquired pneumonia in the US.
    Raut M, Schein J, Mody S, Grant R, Benson C, Olson W.
    Curr Med Res Opin; 2009 Sep 01; 25(9):2151-7. PubMed ID: 19601711
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Cost of intensive care unit-acquired bloodstream infections.
    Laupland KB, Lee H, Gregson DB, Manns BJ.
    J Hosp Infect; 2006 Jun 01; 63(2):124-32. PubMed ID: 16621137
    [Abstract] [Full Text] [Related]

  • 19. The economic impact of aspergillosis: analysis of hospital expenditures across patient subgroups.
    Tong KB, Lau CJ, Murtagh K, Layton AJ, Seifeldin R.
    Int J Infect Dis; 2009 Jan 01; 13(1):24-36. PubMed ID: 18621562
    [Abstract] [Full Text] [Related]

  • 20. [Evaluation of epidemiological characteristics and risk factors of candidemia in adult patients in a tertiary-care hospital].
    Yenigün Koçak B, Kuloğlu F, Doğan Çelik A, Akata F.
    Mikrobiyol Bul; 2011 Jul 01; 45(3):489-503. PubMed ID: 21935782
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.